Parity-to-charge conversion in Majorana qubit readout

MIK Munk, J Schulenborg, R Egger, K Flensberg - Physical Review Research, 2020 - APS
We study the time-dependent effect of Markovian readout processes on Majorana qubits whose
parity degrees of freedom are converted into the charge of a tunnel-coupled quantum dot…

Fidelity and visibility loss in Majorana qubits by entanglement with environmental modes

MIK Munk, R Egger, K Flensberg - Physical Review B, 2019 - APS
We study the dynamics and readout of topological qubits encoded by zero-energy Majorana
bound states in a topological superconductor. We take into account bosonic modes due to …

Dyonic zero-energy modes

MIK Munk, A Rasmussen, M Burrello - Physical Review B, 2018 - APS
One-dimensional systems with topological order are intimately related to the appearance of
zero-energy modes localized on their boundaries. The most common example is the Kitaev …

[PDF][PDF] Meeting the demand for a new generation of flexible and agile manufacturing facilities

A Thomas, M Munk - BioProcess International, 2015 - eu-assets.contentstack.com
Classical stainless steel installations in purpose-built facilities dominate the global capacity
for commercial biopharmaceutical manufacturing. Early facilities that were designed for …

PDA points to consider: technical product lifecycle management. Pharmaceutical quality system effectiveness for managing post-approval changes

…, J Edwards, K O'Donnell, M Jornitz, M Munk… - PDA Journal of …, 2017 - journal.pda.org
Background During the commercial manufacturing phase of the product lifecycle, specific
elements of the PQS are used to identify and manage PACs. Per ICH Q10, these include …

SKP-ordningen udfordringer: En undersøgelse af forholdet mellem intentioner og praksis i Københavns Kommune

JK Ørnbøll, M Munk - 2011 - ucviden.dk
The Support and Contact Scheme (SKP Scheme, Støtte-og kontaktpersonordningen, § 99 in
Lov om Social Service) is an offer available to those addicts, homeless and mentally ill …

PDA PAC iAM 2017 Survey on Post Approval Change: Is the Regulatory Environment Hindering Much-Needed Innovation in the Pharma Industry?

…, K Good, S Kiani, M Jornitz, M Munk… - PDA Journal of …, 2017 - journal.pda.org
… Authors: Members of the PDA Task Force Post Approval Changes for Innovation in
Availability of Medicines (PAC iAM), Emma Ramnarine, Ursula Busse, Marcello Colao, Julia …

PDA Points To Consider: Technical Product Lifecycle Management: Communication and Knowledge Exchange between Marketing Authorization Holders and Health …

…, M Colao, J Edwards, M Jornitz, M Munk… - PDA Journal of …, 2017 - journal.pda.org
… Authors: Members of the PDA Task Force Post Approval Changes for Innovation in
Availability of Medicines (PAC iAM), Emma Ramnarine, Ursula Busse, Marcello Colao, Julia …

[PDF][PDF] Flexible and Agile Facilities of the Future

M Munk, G Moelgaard - Biopharma Asia, 2016 - nne.com
The health care sector requires more and more specialized products, which might only be
used by a small groups of patients, and the regulatory authorities supports this trend by …

What is holding the industry back from implementing CBP (Continuous Bioprocessing) more broadly?

M Munk - 2015 - dc.engconfintl.org
Morten Munk, "What is holding the industry back from implementing CBP (Continuous
Bioprocessing) more broadly?" in "Integrated Continuous Biomanufacturing II", Chetan Goudar, …